Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Stem Cells (Dayton, Ohio)|July 24, 2012
Deficient DNA damage response and cell cycle checkpoints lead to accumulation of point mutations in human embryonic stem cellsNevila Hyka-Nouspikel, Joëlle Desmarais, Paul J Gokhale, et al.
Human Molecular Genetics|May 25, 2002
A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancerSaeed Rafii, Paul O'Regan, George Xinarianos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2008
Thymidine selectively enhances growth suppressive effects of camptothecin/irinotecan in MSI+ cells and tumors containing a mutation of MRE11Rene Rodriguez, Lasse Tengbjerg Hansen, Geraldine Phear, et al.
The Journal of Urology|May 16, 2006
Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearanceJames W F Catto, Arndt Hartmann, Robert Stoehr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Promoter hypermethylation identifies progression risk in bladder cancerDavid R Yates, Ishtiaq Rehman, Maysam F Abbod, et al.
BJU International|January 20, 2007
Clinically localised prostate cancer is microsatellite stableAbdel-Rahmene Azzouzi, James W F Catto, Ishtiaq Rehman, et al.
Nature|April 15, 2005
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseHelen E Bryant, Niklas Schultz, Huw D Thomas, et al.
European Urology|July 1, 2008
FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumoursJohanna M M van Oers, Ellen C Zwarthoff, Ishtiaq Rehman, et al.
International Journal of Cancer|October 26, 2007
Promoter hypermethylation in circulating blood cells identifies prostate cancer progressionMorgan Rouprêt, Vincent Hupertan, James W F Catto, et al.
Oncogene|December 4, 2003
Distinct patterns of microsatellite instability are seen in tumours of the urinary tractJames W F Catto, Abdel-Rahmene Azzouzi, Najla Amira, et al.
Pageof 4